02/03/2026
February is American Heart Month, and it’s a good time to talk about how estrogen and heart health are discussed today.
Estrogen safety labeling has been updated to reinforce an important message: hormone therapy decisions should be personalized, medically supervised, and based on an individual’s overall health profile — including cardiovascular risk factors.
What’s often missed in headlines is nuance. Age, timing, health history, and formulation all matter. That’s why estrogen therapy is never about blanket recommendations, but careful evaluation and collaboration between patient, provider, and pharmacy.
As a compounding pharmacy, we focus on supporting that individualized approach — ensuring therapies are prepared according to prescription, guidelines, and quality standards.
Heart health deserves thoughtful conversations, not fear-based messaging.
This American Heart Month, follow us or contact our pharmacy team to learn how estrogen therapy is approached with care, context, and safety in mind.